Israel - English - Ministry of Health

rafa laboratories ltd - dipyridamole - tablets - dipyridamole 75 mg - dipyridamole - dipyridamole - as an adjunct to oral anticoagulants for prophylaxis of thromboembolism associated with prosthetic heart valves. reduction of proteinuria in the nephrotis syndrome. treatment of membranoproliferative glomerulonephritis. prevention of pre-eclampsia in the final trimester of pregnancy. prevention of transplant artery stenosis. prevention of post-operative thromboembolic complications of coronary artery surgery. in combination with acetylsalicylic acid in cases of recurrent deep vein thrombosis resistant to oral anticoagulants. prevention of thrombogenic manifestations. as an alternative to exercise stress in thallium myocardial imaging particularly in patients unable to exercise or in those for whom exercise may be contraindicated.

Malta - English - Medicines Authority

actavis uk limited whiddon valley, barnstaple, n. devon, ex32 8ns, united kingdom - dipyridamole - coated tablet - dipyridamole 100 mg - antithrombotic agents

Canada - English - Health Canada

pro doc limitee - dipyridamole - tablet - 50mg - dipyridamole 50mg - miscellaneous vasodilatating agents

Canada - English - Health Canada

pro doc limitee - dipyridamole - tablet - 25mg - dipyridamole 25mg - miscellaneous vasodilatating agents

Canada - English - Health Canada

pro doc limitee - dipyridamole - tablet - 75mg - dipyridamole 75mg - miscellaneous vasodilatating agents

Canada - English - Health Canada

pro doc limitee - dipyridamole - tablet - 25mg - dipyridamole 25mg - miscellaneous vasodilatating agents

Canada - English - Health Canada

pro doc limitee - dipyridamole - tablet - 50mg - dipyridamole 50mg - miscellaneous vasodilatating agents

Canada - English - Health Canada

pro doc limitee - dipyridamole - tablet - 75mg - dipyridamole 75mg - miscellaneous vasodilatating agents

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - dipyridamole - coated tablet - dipyridamole 100 mg - antithrombotic agents

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - dipyridamole 150mg - modified release capsule - 150 mg - active: dipyridamole 150mg excipient: gelatin   hyprolose hypromellose methacrylic acid - methyl methacrylate copolymer (1:2) (eudragit s 100) iron oxide black purified talc tartaric acid titanium dioxide   triethyl citrate - latest regulatory activity